ClinicalTrials.Veeva

Menu

Tetragraph® Monitor: Tolerance of Preoperative Placement

J

Joseph D. Tobias

Status

Completed

Conditions

Surgery

Treatments

Device: TetraGraph NMT Monitor

Study type

Interventional

Funder types

Other

Identifiers

NCT05964166
STUDY00003295

Details and patient eligibility

About

This is a prospective, non-blinded, single arm study. The primary objective of this study is to evaluate the tolerance to preoperative placement of the adhesive sensor for the Tetragraph® Neuromuscular Transmission Monitor in pediatric-sized patients ≤ 12 years of age.

Enrollment

40 patients

Sex

All

Ages

3 months to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients requiring anesthetic care and use of neuromuscular blockade
  2. Age ≤ 12 years
  3. ASA 1-4

Exclusion criteria

  1. History of a peripheral neurologic or neuropathic disorder
  2. Upper extremity cannot be used for TOF monitoring
  3. Undergoing a surgical procedure in which neuromuscular blockade is not required
  4. Patient is edematous
  5. Patients with significant behavioral or neurocognitive issues which affect behavior and impact the ability to place the sensor

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Tetragraph
Experimental group
Treatment:
Device: TetraGraph NMT Monitor

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems